Ind-Swift Lab Reports Q1 EBITDA Turnaround, Revenue Growth Amid Profit Decline 5 days ago
Ind Swift Laboratories Limited reported mixed Q1 financial results. The company achieved an EBITDA turnaround, posting ₹36.00 million compared to a ₹65.00 million loss in the previous year, with an EBITDA margin of 2.36%. Revenue grew by 4.08% to ₹1.53 billion. However, consolidated net profit declined by 69.86% to ₹88.00 million from ₹292.00 million in the same quarter last year. The board approved these unaudited results in a meeting on August 13.
Ind Swift Laboratories Reports Strong Profit Growth and Completes Merger with Ind Swift Limited 7 days ago
Ind-Swift Laboratories Merger with Ind-Swift Limited Gets NCLT Approval, Effective August 8, 2025 Jul 31, 2025
Ind-Swift Laboratories Secures NCLT Approval for Merger with Ind-Swift Limited Jul 28, 2025
Ind-Swift Laboratories Invests ₹950 Million in Khandelwal Finance's OCRPS Jun 18, 2025
Ind-Swift Laboratories Ltd (ISLL) has approved a short-term advance of up to Rs 20 crore to Ashok Investors Trust Limited (AITL), a registered NBFC. The advance is in the form of an Inter-Corporate Deposit with a 30-day term, extendable for another 30 days, at 10% annual interest. The transaction is secured by post-dated cheques and is not a related party transaction. ISLL already holds 800 NCDs of AITL, each with a face value of Rs 5,00,000.